To find possible therapeutic targets to help prevent long-term brain and behavioural side effects in survivors of childhood leukemia that may have been caused by chemotherapy (Treatment-Related late Adverse Neuro-Cognitive Effects: TRANCE). The study hypothesis is that genetic variations of the elements in the folate-related cycles and methotrexate disposition networks are associated with the deficit phenotype (TRANCE) of childhood leukemia survivors.
Hypothesis Genetic variants of the elements in the folate-related cycles and methotrexate disposition networks are associated with the TRANCE phenotype of childhood leukemia survivors. Objectives 1. To identify TRANCE phenotypes of the childhood leukemia survivors. 2. To characterize the folate and vitamin B12 levels of these children 3. To identify DNA methylation patterns associated with TRANCE trait in the leukemia survivors 4. To identify SNPs associated with the TRANCE trait in the leukemia survivors. 5. To identify the "deficit genotype" associated only with the TRANCE leukemia survivors, but not with general population children who show developmental phenotypes similar to TRANCE: TRANCE-unique deficit variant 6. To replicate the association between the TRANCE-unique deficit variants and the TRANCE trait in a population of childhood leukemia survivors. 7. To evaluate the importance of rare genetic variants in the TRANCE trait in the leukemia survivors. Study design: A case-control study of leukemia survivors Analyses 1. Leukemia survivors will be characterized by their status of neurocognitive function, and categorized into the Deficit case and the non-deficit Control case. 2. They will be also characterized by the following attributes 1. Pathway-based genetic variant status (folate and PK-related genes) 2. Folate and vitamin B12 status 3. Epigenetic markers 3. Comparative analyses between neuro-cognitiive deficit phenotype (TRANCE) and Control on those parameters
Study Type
OBSERVATIONAL
Enrollment
204
The Hospital for Sick Children
Toronto, Ontario, Canada
DIVERGET
This is a short battery of tests that has been shown to be predictive of both global and academic impairment in survivors of childhood cancer. All neuro-cognitive tests are done on a same day.
Time frame: Within 6 months from the enrolment
Stop Signal Task (SST)
Response inhibition, disturbed by behavioral inattention, will be characterized using our task-based computer program, the Stop Signal Task (SST). All neuro-cognitive tests are done on a same day.
Time frame: Within 6 months from the enrolment
CONNERS 3
To characterize behavioural aspects, we will administer the standard measure based on parent report. All neuro-cognitive tests are done on a same day.
Time frame: Within 6 months from the enrolment
Pathway-based gene variant status
In the hypothesis-driven genome-wide approach, we will focus on the candidate pathways/regions including (but not limited to): a) Folate/methionine cycle genes and transporters; b) drug metabolizing enzymes and transporters (including families of CYP, SLC and ABC transporters); c) epigenetic modifying factors; and d) neuro-regeneration and tissue repair.
Time frame: Within 3 months from the end of enrolment
WISC-IV
In order to confirm validity of DIVERGT in our sample, and provide the data source for future studies, we will include tests of general cognitive function (WISC-IV). All neuro-cognitive tests are done on a same day.
Time frame: Within 6 months from the enrolment
WIAT-III numerical operations and math fluency composite score
In order to confirm validity of DIVERGT in our sample, and provide the data source for future studies, we will include tests of general cognitive function: WIAT-III numerical operations and math fluency composite score. All neuro-cognitive tests are done on a same day.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Within 6 months from the enrolment
Brief Rating Inventory of Executive Function (BRIEF)
In order to confirm validity of DIVERGT in our sample, and provide the data source for future studies, we will administer Brief Rating Inventory of Executive Function (BRIEF), which is designed to assess executive functioning in the home environment. All neuro-cognitive tests are done on a same day.
Time frame: Within 6 months from the enrolment
N-Back Task
In order to confirm validity of DIVERGT in our sample, and provide the data source for future studies, we will administer N-Back Task, which is a continuous performance computerized task used to measure aspects of working memory. All neuro-cognitive tests are done on a same day.
Time frame: Within 6 months from the enrolment
Folate, vitamin B12 and iron intake
Folate and other vitamin intakes vary among individuals. Folic acid fortification in Canadian food product has changed the Canadian population norm of folate status, virtually eliminating folate deficiency status. However, a large inter-individual variation still remains. We will use a Supplement Questionnaire to capture information on all and any supplements that participants may be currently taking.
Time frame: Within 6 months from the enrolment
Folate status
In order to complement the Supplement Questionnaire (above), we will measure the folate concentration in plasma and red blood cells.
Time frame: Within 6 months from the enrolment
Serum vitamin B12
Vitamin B12 and folate pathways interact to maintain biochemical homeostasis. To complement the intake assessment (above), we will measure serum vitamin B12.
Time frame: Within 6 months from the enrolment
Iron status
Iron status affects cognitive function of children. In addition to the intake assessment (above), we will estimate iron status by measuring hemoglobin and soluble transferrin receptor.
Time frame: Within 6 months from the enrolment